No photo of Sergei Kotenko

View Scopus Profile

Sergei Kotenko

  • 11300 Citations
  • 53 h-Index
1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sergei Kotenko is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection

Kotenko, S. & Durbin, J.

National Institutes of Health

1/18/13 → 12/31/18

Project: Research project

    • Evasion of antiviral protection by poxvirus-encoded interferon antagonists

    Kotenko, S.

    National Institutes of Health

    6/5/09 → 5/31/12

    Project: Research project

    • Role of Interferon-lambda in Antiviral Response

    Kotenko, S.

    National Institutes of Health

    12/16/04 → 11/30/09

    Project: Research project

    • Characterization of the IL-TIF Receptor Complex

    Kotenko, S.

    National Institutes of Health

    5/3/01 → 4/30/07

    Project: Research project

    • Research Output

    COVID-19 and emerging viral infections: The case for interferon lambda

    Prokunina-Olsson, L., Alphonse, N., Dickenson, R. E., Durbin, J. E., Glenn, J. S., Hartmann, R., Kotenko, S. V., Lazear, H. M., O’Brien, T. R., Odendall, C., Onabajo, O. O., Piontkivska, H., Santer, D. M., Reich, N. C., Wack, A. & Zanoni, I., May 4 2020, In : Journal of Experimental Medicine. 217, 5, e20200653.

    Research output: Contribution to journal › Review article

    Open Access
    • 32 Scopus citations

    Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus

    Goel, R. R., Wang, X., O’Neil, L. J., Nakabo, S., Hasneen, K., Gupta, S., Wigerblad, G., Blanco, L. P., Kopp, J. B., Morasso, M. I., Kotenko, S. V., Yu, Z. X., Carmona-Rivera, C. & Kaplan, M. J., Mar 10 2020, In : Proceedings of the National Academy of Sciences of the United States of America. 117, 10, p. 5409-5419 11 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    Pan-TAM tyrosine kinase inhibitor BMS-777607 Enhances Anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer

    Kasikara, C., Davra, V., Calianese, D., Geng, K., Spires, T. E., Quigley, M., Wichroski, M., Sriram, G., Suarez-Lopez, L., Yaffe, M. B., Kotenko, S. V., De Lorenzo, M. S. & Birge, R. B., Jan 1 2019, In : Cancer Research. 79, 10, p. 2669-2683 15 p.

    Research output: Contribution to journal › Article

    • 14 Scopus citations

    Phosphoinositide 3-kinase signaling can modulate MHC Class i and II expression

    Chandrasekaran, S., Sasaki, M., Scharer, C. D., Kissick, H. T., Patterson, D. G., Magliocca, K. R., Seykora, J. T., Sapkota, B., Gutman, D. A., Cooper, L. A., Lesinski, G. B., Waller, E. K., Thomas, S. N., Kotenko, S. V., Boss, J. M., Moreno, C. S., Swerlick, R. A. & Pollack, B. P., Jan 1 2019, In : Molecular Cancer Research. 17, 12, p. 2395-2409 15 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Real-time 2-5A kinetics suggest that interferons β and λ evade global arrest of translation by RNase L

    Chitrakar, A., Rath, S., Donovan, J., Demarest, K., Li, Y., Sridhar, R. R., Weiss, S. R., Kotenko, S. V., Wingreen, N. S. & Korennykh, A., Feb 5 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 6, p. 2103-2111 9 p.

    Research output: Contribution to journal › Article

    • 8 Scopus citations